NCT02242643 · Interventional trial
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age
Overall registry status Completed
Phase 3
Conditions Influenza
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
- GSK Investigational Site · Sellersville, PA · Bucks County
First posted
Registry updated
Added to the directory